In addition, a small molecule APOE4− targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model54, suggesting the potential APOE4 and Sirt1 pathways. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.